Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines?Investors Business Daily • 10/26/25
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025PRNewsWire • 10/08/25
Penumbra, Inc. (PEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk ProfilePRNewsWire • 09/09/25
Penumbra, Inc. (PEN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/03/25
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth ConferencePRNewsWire • 07/30/25
Penumbra (PEN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/29/25
Will Penumbra (PEN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/24/25
Penumbra (PEN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/22/25
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025PRNewsWire • 07/01/25
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled TrialPRNewsWire • 06/16/25